IP Verse

Irm Llc opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Mar 25, 2020

Title:

Cancer Patient Selection For Administration Of Wnt Signaling Inhibitors Using Rnf43 Mutation Status

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP2820151	Mar 25, 2020	Cancer Patient Selection For Administration Of Wnt Signaling Inhibitors Using Rnf43 Mutation Status	1

BOEHRINGER INGELHEIM RCV GMBH & CO KG / BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Feel free to send us a message here and we will get back to you